ストックスクリーナーアプリを入手
0.1295
9.19%
-0.0131
アフターアワーズ：
.12
-0.0095
-7.34%
前日終値:
$0.1426
開ける：
$0.124
24時間の取引高:
11.34M
Relative Volume:
0.62
時価総額：
$6.55M
収益：
-
当期純損益:
$-11.00M
株価収益率:
-0.3274
EPS:
-0.3956
ネットキャッシュフロー:
$-11.99M
1週間 パフォーマンス:
+17.30%
1か月 パフォーマンス:
-8.93%
6か月 パフォーマンス:
-86.22%
1年 パフォーマンス:
-98.13%
1日の値動き範囲:
$0.11
$0.1389
1週間の範囲:
$0.0962
$0.207
52週間の値動き範囲:
$0.095
$9.38
Liminatus Pharma Inc Stock (LIMN) Company Profile
Compare LIMN vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
0.1295 | 7.22M | 0 | -11.00M | -11.99M | -0.3956 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Liminatus Pharma Inc (LIMN) 最新ニュース
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Price to earnings forward of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
Form 4 Liminatus Pharma Inc For: 6 July By Investing.com - Investing.com Canada
4.37M Liminatus (NASDAQ: LIMN) shares moved in entity transfer - Stock Titan
Liminatus Pharma Closes InnocsAI Merger and Share Issuance - TipRanks
LIMNLiminatus Pharma Inc Options - Finviz
LIMN Should I Buy - Intellectia AI
Thursday's session: most active stocks - ChartMill
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Liminatus Pharma (LIMN) stock is trending overnight — here’s why it spiked over 30% in after-hours session (updated) - MSN
Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Sessio - Benzinga
Liminatus amends InnocsAI merger, closing set for July 2 - Investing.com
Trending Stocks Today | LogProStyle Surges 72.41% Post-Market - Moomoo
Wondering what's happening in today's after-hours session? - ChartMill
Liminatus amends InnocsAI merger, closing set for July 2 By Investing.com - Investing.com Canada
Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline - The Manila Times
Liminatus pushes $320M InnocsAI merger to July 2 close - Stock Titan
Form PRE 14A Liminatus Pharma Inc For: 30 June By Investing.com - Investing.com Nigeria
Liminatus Pharma (LIMN) Edges Higher Amid Penny Stock VolatilityVolatility Stop - dars.gov.et
Liminatus Pharma (LIMN) Stock Forum and Discussion - Moomoo
Form S-1 Liminatus Pharma Inc For: 24 June By Investing.com - Investing.com Nigeria
Liminatus (NASDAQ: LIMN) resale S-1 and 1.6B-share InnocsAI merger plan - Stock Titan
Liminatus Pharma (LIMN) Faces Selling Pressure, Testing Key Support at $0.11Money Flow - newsline.com
Liminatus Pharma Warrants (LIMNW) Holds at $0.08 as Trading StallsPut Flow Alert - newsline.com
Liminatus Pharma (LIMN) Extends Decline, Testing Key Support at $0.11OBV Breakout - newsline.com
Liminatus Pharma Warrants (LIMNW) Hold Steady Near Key Support LevelVolume Oscillator - newsline.com
Liminatus Pharma (LIMN) Slips 5.77% as Selling Pressure Persists Below $0.14 ResistanceJelly Roll Trade - newsline.com
Liminatus Pharma Inc. (LIMN) Slides 5.95% as Stock Tests Key Support at $0.13Regression Channel - newsline.com
Liminatus Pharma secures $1.9M cash via warrant exercises - MSN
Liminatus Pharma Secures Liquidity Through Warrant Inducement Deal - TipRanks
[8-K] Liminatus Pharma, Inc. Reports Material Event - Stock Titan
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds - The Manila Times
Liminatus Pharma (NASDAQ: LIMN) cuts warrant exercise price; 13.8M warrants tied to 20.7M shares - Stock Titan
Liminatus Pharma (LIMN) Slides 8.89%: Testing Key $0.15 Support LevelVolatility Stop - newsline.com
Liminatus Pharma (LIMN) Slips 6% as Stock Tests Key Support at $0.16Order Block - newsline.com
LIMINATUS PHARMA, INC. Files Form 8-K for NASDAQ Listing – Company Information and SEC Filing Details - Minichart
Liminatus Pharma (LIMN) Holds Steady Near Resistance – Consolidation Phase May Precede Directional MoveSentiment Extreme - newsline.com
Liminatus Pharma Appeals Nasdaq Delisting, Listing Temporarily Intact - TipRanks
Liminatus Pharma Received Notice of Delisting - TradingView
Liminatus Pharma (LIMN) appeals Nasdaq delisting after market value shortfall - Stock Titan
Liminatus Pharma Inc. (LIMN) Surges Over 12% as Bullish Momentum BuildsBPI Reversal - The Legal Advocate
Liminatus Pharma - The Pharma Letter
Liminatus Pharma (LIMN) Shares Slide 3.25% as Selling Pressure Mounts Near SupportRetail Volume - newsline.com
Liminatus Pharma(LIMN) Stock Options Chain | Quotes & News - Moomoo
Liminatus announces proposed merger with InnocsAI - The Pharma Letter
Liminatus Pharma notifies NASDAQ of impending delisting; plans to appeal - MSN
Liminatus Pharma is trending overnight — here's why LIMN stock surged over 79% in after-hours session - MSN
Liminatus Pharma (LIMN) Faces Delisting from Nasdaq - GuruFocus
Liminatus Pharma (LIMN) Faces Nasdaq Delisting Notice Amid Compl - GuruFocus
Liminatus Pharma Inc (LIMN) 財務データ
収益
当期純利益
現金流量
EPS
1.17%
2.48%
大文字化:
|
ボリューム (24 時間):